In TME, CD169 promotes cytotoxic T lymphocyte response, and the infiltration of CD169+ macrophages in the tumor enhances the cytotoxicity, proliferation, and cytokine production of CD8+ T cells [40]. The gene discussed is SIGLEC1; the disease is neoplasm.